TOP NEWS

Evofem Biosciences Raises $50M In Offering

San Diego-based Evofem Biosciences, a developer of biopharmaceuticals for female reproductive health, reported it raised $50M in its previously announced public offering. It said it will net approximately $46.6M after underwriting discounts, commissions, and expenses. The company sold 50 million shares of its common stock, plus two year warrants on up to

The story you have requested is only available to paid members of the socalTECH.com web site. Premium articles are restricted to paid members only. Please login in order to access this members-only content, or become a member.